Eton Pharmaceuticals Inc Revenue per Employee (ETON), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Eton Pharmaceuticals Inc   (NASDAQ: ETON)
 

Eton Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 165.04% in the third quarter 2026, year on year to cumulative value of $141 million, Eton Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 3,212,477, this is below the company average.
Within the Healthcare sector Employees of 32 other companies have achieved higher revenue per employee. While Eton Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 405 to 438. Eton Pharmaceuticals Inc has 44 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ETON Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 165.04 % 98.63 % 40.77 % 77.14 % 112.14 %
Sales per Employee (TTM) $ 3,212,477 2,392,705 1,968,500 1,812,273 1,593,545
ETON's Total Ranking # 438 # 405 # 422 # 340 #
Seq. Revenue Change 54.1 % 58.37 % 7.4 % 1.12 % 15.49 %

ETON Company Profile >> Back to ETON Efficiency Comparisons >> Compare ETON Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 23
Healthcare Sector # 33
Overall Market # 438

Revenue per Employee Statistics
High Average Low
$ 2,392,705 $ 789,477 $ 7,432
(Jun 30 2026)   (Dec 31 2020)



Financial Statements
Eton Pharmaceuticals Inc 's Revenue MRQ $ 58 Millions Visit ETON's Income Statement
Eton Pharmaceuticals Inc 's Revenues TTM $ 141 Millions Visit ETON's aggregate revenue growth
What are ETON's Sales? Visit ETON's Sales by Segment




Other Ratios
Eton Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ETON's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ETON's Competitors
Revenue per Employee for ETON's Suppliers
Revenue per Employee for ETON's Customers

You may also want to know
ETON's Sales Growth Rates ETON's Pe Price to earnings ratio ETON's Receivables Turnover Ratio ETON's Stock Quote
ETON's Net Income Growth Rates ETON's Ps Price to Sales ratio ETON's Sales per Employee ETON's Asset Turnover Ratio
ETON's Net Margin ETON's Pb Price to Book ratio ETON's Financial Strength Ratios ETON's Dividend Payout Ratio
Date modified: 2026-11-06T13:02:44+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Ligand Pharmaceuticals Incorporated  5,400,574.47 $ 253.827  Million 47 
Halozyme Therapeutics Inc   4,261,106.38 $ 1,802.448  Million 423 
Ironwood Pharmaceuticals inc   4,002,960.00 $ 400.296  Million 100 
Community Health Systems Inc   3,759,032.26 $ 11,653.000  Million 3,100 
Illumina Inc   3,545,312.50 $ 4,538.000  Million 1,280 
Amgen Inc   2,992,538.46 $ 38,903.000  Million 13,000 
Kiniksa Pharmaceuticals International Plc  2,584,598.36 $ 945.963  Million 366 
Aurinia Pharmaceuticals Inc   2,513,578.12 $ 321.738  Million 128 
Sarepta Therapeutics Inc   2,342,920.96 $ 1,956.339  Million 835 
Zevra Therapeutics Inc   2,304,065.57 $ 140.548  Million 61 
Nurix Therapeutics Inc   2,214,309.15 $ 701.936  Million 317 
Exelixis Inc   2,176,862.25 $ 2,496.861  Million 1,147 
Incyte Corporation  2,113,485.94 $ 6,010.754  Million 2,844 
Alnylam Pharmaceuticals Inc   2,005,296.80 $ 5,013.242  Million 2,500 
Neurocrine Biosciences Inc   1,850,850.00 $ 3,701.700  Million 2,000 
Tarsus Pharmaceuticals Inc   1,843,791.89 $ 682.203  Million 370 
Gilead Sciences Inc   1,822,823.53 $ 30,988.000  Million 17,000 
Mirum Pharmaceuticals Inc   1,803,166.67 $ 670.778  Million 372 
Eli Lilly And Company  1,729,240.00 $ 86,462.000  Million 50,000 
Alector Inc   1,684,165.05 $ 173.469  Million 103 
Rigel Pharmaceuticals Inc  1,656,396.55 $ 288.213  Million 174 
Jazz Pharmaceuticals Plc  1,632,569.55 $ 4,718.126  Million 2,890 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.